Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.116.238493
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

CETSA-based Target Engagement of Taxanes as Biomarkers for Efficacy and Resistance

Scientific Reports
Multidisciplinary
2019English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

A Novel Method of Inducing Thrombosis in Target Arteries Using Coronary Stents for Therapeutic Occlusion

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2018English

Αvβ1 Integrin as a Novel Therapeutic Target for Tissue Fibrosis

Annals of Translational Medicine
Medicine
2016English

Tumour Necrosis Factor (TNF ) as a Novel Therapeutic Target in Symptomatic Corticosteroid Dependent Asthma

Thorax
PulmonaryRespiratory Medicine
2005English

A Novel Method for Target Detection

2015English

A Crucial Role of MafA as a Novel Therapeutic Target for Diabetes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

COL12A1, a Novel Potential Prognostic Factor and Therapeutic Target in Gastric Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer

AAPS Journal
Pharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy